article image

Quick Quotes

“The agency could be in a position to act very quickly, depending on what the outcome of that meeting is.”

Former FDA Commissioner Scott Gottlieb on booster or third-dose COVID-19 vaccines.

Published on

sep 13, 2021

  • An advisory panel will meet on Friday to discuss specifically Pfizer's application for a third or "booster" dose of the vaccine.
  • Dr. Gottlieb (also on the board of Pfizer) says he believes the boosters will likely be prioritized for those older and more at risk for severe implications from COVID-19.

Why It Matters: Questions about vaccine efficacy remain as the United States nears a year since the first dose was administered to the public but infections continue to rise nationwide.

Here's the link to the FDA meeting.

Link to Dr. Gottlieb's interview: CLICK HERE

Sign up today to

Get SmartHER News In Your Inbox

Read our Privacy Policy